The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Phantom PAINS: Problems with the Utility of Alerts for P an-A ssay IN terference Compound S
Open accessAbstract
The use of substructural alerts to identify Pan-Assay INterference compoundS (PAINS) has become a common component of the triage process in biological screening campaigns. These alerts, however, were originally derived from a proprietary library tested in just six assays measuring protein-protein interaction (PPI) inhibition using the AlphaScreen detection technology only; moreover, 68% (328 out of the 480 alerts) were derived from four or fewer compounds. In an effort to assess the reliability of these alerts as indicators of pan-assay interference, we performed a large-scale analysis of the impact of PAINS alerts on compound promiscuity in bioassays using publicly available data in PubChem. We found that the majority (97%) of all compounds containing PAINS alerts were actually infrequent hitters in AlphaScreen assays measuring PPI inhibition. We also found that the presence of PAINS alerts, contrary to expectations, did not reflect any heightened assay activity trends across all assays in PubChem including AlphaScreen, luciferase, beta-lactamase, or fluorescence-based assays. In addition, 109 PAINS alerts were present in 3570 extensively assayed, but consistently inactive compounds called Dark Chemical Matter. Finally, we observed that 87 small molecule FDA-approved drugs contained PAINS alerts and profiled their bioassay activity. Based on this detailed analysis of PAINS alerts in nonproprietary compound libraries, we caution against the blind use of PAINS filters to detect and triage compounds with possible PAINS liabilities and recommend that such conclusions should be drawn only by conducting orthogonal experiments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 3,944
ZINC 15 – Ligand Discovery for Everyone
Sterling, T., & Irwin, J. J. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00559 · Cited by 3,224
Policy: NIH plans to enhance reproducibility
Collins, F. S., & Tabak, L. A. (2014) · Nature · doi:10.1038/505612a · Cited by 1,247
Baell, J. B. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00947 · Cited by 539
Apparent activity in high-throughput screening: origins of compound-dependent assay interference
Thorne, N., Auld, D. S., & Inglese, J. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.03.020 · Cited by 430
Dahlin, J. L., Nissink, J. W. M., Strasser, J. M., Francis, S., Higgins, L., Zhou, H., Zhang, Z., & Walters, M. A. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm5019093 · Cited by 351
Rules for Identifying Potentially Reactive or Promiscuous Compounds
Bruns, R. F., & Watson, I. A. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301008n · Cited by 338
Drug repurposing: far beyond new targets for old drugs
Oprea, T. I., & Mestres, J. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9390-1 · Cited by 285
FAF-Drugs3: a web server for compound property calculation and chemical library design
Lagorce, D., Sperandio, O., Baell, J. B., Miteva, M. A., & Villoutreix, B. O. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv353 · Cited by 272
Dark chemical matter as a promising starting point for drug lead discovery
Wassermann, A. M., Lounkine, E., Hoepfner, D., Goff, G. L., King, F. J., Studer, C., Peltier, J. M., Grippo, M. L., Prindle, V. C., Tao, J., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1936 · Cited by 138
Alarms about structural alerts
Alves, V. M., Muratov, E. N., Capuzzi, S. J., Politi, R., Low, Y., Braga, R. C., Zakharov, A. V., Sedykh, A., Mokshyna, E., Farag, S., et al. (2016) · Green Chemistry · doi:10.1039/c6gc01492e · Cited by 133
Self-citationColloidal Aggregation Causes Inhibition of G Protein-Coupled Receptors
Sassano, M. F., Doak, A. K., Roth, B. L., & Shoichet, B. K. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301749y · Cited by 110
Badapple: promiscuity patterns from noisy evidence
Yang, J. J., Ursu, O., Lipinski, C. A., Sklar, L. A., Oprea, T. I., & Bologa, C. G. (2016) · Journal of Cheminformatics · doi:10.1186/s13321-016-0137-3 · Cited by 103
Alves, V. M., Muratov, E. N., Fourches, D., Strickland, J. A., Kleinstreuer, N., Andrade, C. H., & Tropsha, A. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.12.014 · Cited by 102
Self-citationWilliamson, A. E., Ylioja, P. M., Robertson, M. N., Antonova‐Koch, Y., Avery, V. M., Baell, J. B., Batchu, H., Batra, S., Burrows, J. N., Bhattacharyya, S. S., et al. (2016) · ACS Central Science · doi:10.1021/acscentsci.6b00086 · Cited by 102
Filtering promiscuous compounds in early drug discovery: is it a good idea?
Senger, M. R., Fraga, C. A. M., Dantas, R. F., & Silva, F. P. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.02.004 · Cited by 95
Identification of Small-Molecule Frequent Hitters from AlphaScreen High-Throughput Screens
Schorpp, K., Rothenaigner, I., Salmina, E. S., Reinshagen, J., Low, T., Brenke, J. K., Gopalakrishnan, J., Tetko, I. V., Gul, S., & Hadian, K. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113516861 · Cited by 92
Neves, B. J., Dantas, R. F., Senger, M. R., Melo-Filho, C. C., Valente, W. C. G., de Almeida, A. C. M., Rezende-Neto, J. M., Lima, E. F. C., Paveley, R. A., Furnham, N., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b02038 · Cited by 91
Self-citationHow to Triage PAINS-Full Research
Dahlin, J. L., & Walters, M. A. (2015) · Assay and Drug Development Technologies · doi:10.1089/adt.2015.674 · Cited by 85
Tackling reproducibility in academic preclinical drug discovery
Frye, S. V., Arkin, M. R., Arrowsmith, C. H., Conn, P. J., Glicksman, M. A., Hull-Ryde, E. A., & Slusher, B. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4737 · Cited by 84
Alves, V. M., Muratov, E. N., Fourches, D., Strickland, J. A., Kleinstreuer, N., Andrade, C. H., & Tropsha, A. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.12.013 · Cited by 83
Self-citationScreening-Based Translation of Public Research Encounters Painful Problems
Baell, J. B. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00032 · Cited by 65
QSAR models of human data can enrich or replace LLNA testing for human skin sensitization
Alves, V. M., Capuzzi, S. J., Muratov, E. N., Braga, R. C., Thornton, T., Fourches, D., Strickland, J. A., Kleinstreuer, N., Andrade, C. H., & Tropsha, A. (2016) · Green Chemistry · doi:10.1039/c6gc01836j · Cited by 62
Self-citationQuantification of Frequent-Hitter Behavior Based on Historical High-Throughput Screening Data
Nissink, J. W. M., & Blackburn, S. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.72 · Cited by 57
Schürer, S. C., Vempati, U. D., Smith, R. P., Southern, M. R., & Lemmon, V. (2011) · SLAS DISCOVERY · doi:10.1177/1087057111400191 · Cited by 52
Determining the Degree of Promiscuity of Extensively Assayed Compounds
Jasial, S., Hu, Y., & Bajorath, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153873 · Cited by 42
Erlanson, D. A. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00294 · Cited by 33
Mok, N. Y., Maxe, S., & Brenk, R. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci300382f · Cited by 23
Expanding the scope of drug repurposing in pediatrics: The Children's Pharmacy Collaborative™
Blatt, J., Farag, S., Corey, S. J., Sarrimanolis, Z., Muratov, E. N., Fourches, D., Tropsha, A., & Janzen, W. P. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.08.003 · Cited by 22
Self-citationPubChem promiscuity: a web resource for gathering compound promiscuity data from PubChem
Canny, S., Cruz, Y., Southern, M. R., & Griffin, P. R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr622 · Cited by 21
One Size Does Not Fit All: Challenging Some Dogmas and Taboos in Drug Discovery
Chai, C. L. L., & Mátyus, P. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.167 · Cited by 20
Cited by
Molecular Sets (MOSES): A Benchmarking Platform for Molecular Generation Models
Polykovskiy, D., Zhebrak, A., Sanchez-Lengeling, B., Golovanov, S., Tatanov, O., Belyaev, S., Kurbanov, R., Artamonov, A., Aladinskiy, V., Veselov, M., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.565644 · Cited by 849
Seven Year Itch: Pan-Assay Interference Compounds (PAINS) in 2017—Utility and Limitations
Baell, J. B., & Nissink, J. W. M. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.7b00903 · Cited by 648
An open-source drug discovery platform enables ultra-large virtual screens
Gorgulla, C., Boeszoermenyi, A., Wang, Z.-F., Fischer, P. D., Coote, P. W., Padmanabha Das, K. M., Malets, Y. S., Radchenko, D. S., Moroz, Y. S., Scott, D. A., et al. (2020) · Nature · doi:10.1038/s41586-020-2117-z · Cited by 641
A practical guide to large-scale docking
Bender, B. J., Gahbauer, S., Luttens, A., Lyu, J., Webb, C. M., Stein, R. M., Fink, E. A., Balius, T. E., Carlsson, J., Irwin, J. J., et al. (2021) · Nature Protocols · doi:10.1038/s41596-021-00597-z · Cited by 546
Chalcone Derivatives: Promising Starting Points for Drug Design
Gomes, M., Muratov, E., Pereira, M., Peixoto, J., Rosseto, L., Cravo, P., Andrade, C., & Neves, B. (2017) · Molecules · doi:10.3390/molecules22081210 · Cited by 418
Self-citation
Metadata
- Authors
- Capuzzi, S. J., Muratov, E. N., & Tropsha, A.
- Venue
- Journal of Chemical Information and Modeling
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-02-25
- Volume
- 57
- Issue
- 3
- Pages
- 417-427
- ISSN
- 1549-9596 (ISSN-L)
- 1549-960X
- OpenAlex
- W2586253560
- Cited by
- 260
- References
- 31
- FWCI
- 26.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.